Search results
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 14 hours agoPNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
ThePress.net· 1 day agoInhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") announced that, at a special meeting (the "Special Meeting"), the Company's stockholders approved the sale to Sanofi
Sanofi Drug Shows Promise in Asthma After Blood Disorder Success
Bloomberg· 3 days agoA Sanofi experimental drug showed promise in treating asthma, supporting the French drugmaker’s plan...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via AOL· 3 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
Sanofi partners with OpenAI: here's how it will mitigate AI risks | Invezz
Invezz· 4 days agoSanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial...
Q3 2024 EPS Estimates for Sanofi (NASDAQ:SNY) Increased by Analyst
ETF DAILY NEWS· 4 days agoSanofi (NASDAQ:SNY – Free Report) – Research analysts at Zacks Research raised their Q3 2024 EPS estimates for Sanofi in a report released on Thursday, ...
Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
Reuters via Yahoo Finance· 3 days agoA judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million...
Sanofi enters partnership to enhance drug development using AI
Pharmaceutical Technology via Yahoo Finance· 4 days agoSanofi has collaborated with Formation Bio and OpenAI to harness AI to expedite drug development. To...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks via Yahoo Finance· 4 days agoSanofi SNY announced that it has entered into a first-in-class artificial intelligence (AI)...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoSanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...